L
Lori E. Dodd
Researcher at University of California
Publications - 2
Citations - 5919
Lori E. Dodd is an academic researcher from University of California. The author has contributed to research in topics: ZMapp & Sierra leone. The author has an hindex of 2, co-authored 2 publications receiving 3749 citations.
Papers
More filters
Journal ArticleDOI
Remdesivir for the Treatment of Covid-19 - Final Report.
John H. Beigel,Kay M. Tomashek,Lori E. Dodd,Aneesh K. Mehta,Barry S. Zingman,Andre C. Kalil,Elizabeth L. Hohmann,Helen Y. Chu,Annie Luetkemeyer,Susan Kline,Diego Lopez de Castilla,Robert W. Finberg,Kerry Dierberg,Victor F. Tapson,Lanny Hsieh,Thomas F. Patterson,Roger Paredes,Daniel A. Sweeney,William R. Short,Giota Touloumi,David Chien Lye,Norio Ohmagari,Myoung-don Oh,Guillermo M. Ruiz-Palacios,Thomas Benfield,Gerd Fätkenheuer,Mark G. Kortepeter,Robert L. Atmar,C. Buddy Creech,JD Lundgren,Abdel G. Babiker,Sarah Pett,James D. Neaton,Timothy Burgess,Tyler Bonnett,Michelle Green,Mat Makowski,Anu Osinusi,Seema U Nayak,H. Clifford Lane +39 more
TL;DR: The data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.
Journal ArticleDOI
A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection.
Richard T. Davey,Lori E. Dodd,Michael A. Proschan,James D. Neaton,Neuhaus Nordwall J,Joseph S. Koopmeiners,John H. Beigel,Tierney J,H C Lane,Anthony S. Fauci,Massaquoi Mbf,Foday Sahr,Denis Malvy +12 more
TL;DR: In this randomized, controlled trial of a putative therapeutic agent for EVD, although the estimated effect of ZMapp appeared to be beneficial, the result did not meet the prespecified statistical threshold for efficacy.